Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 1, 2001, Pages 92-96

  LiPuma, J J ^a   Spilker, T ^a   Gill, L H ^a   Campbell III, P W ^a   Liu, L ^a   Mahenthiralingam, E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE TRANSMISSION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPECIES DIFFERENCE;

EID: 0035402363     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.1.2011153     Document Type: Article

References (22)

1. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
2. Burkholderia cepacia. Management issues and new insights
3. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
4. 2-fixing isolates from rice in Vietnam
5. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV)
6. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients
7. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex comprising biocontrol and cystic fibrosis-related isolates
8. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis
9. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
10. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers
11. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis
12. Cable (cbl) type II pill of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: Nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers
13. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland
14. Distribution of genes encoding putative transmissibility factors among epidemic and non-epidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom
15. Misidentification of Burkholderia cepacia in US Cystic fibrosis treatment centers: An analysis of 1,051 recent sputum isolates
16. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia Genomovars I and II
17. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex
18. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
19. Detection, recovery and identification of Burkholderia cepacia from the natural environment
20. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers
21. The emergence of a highly transmissible lineage of cbl+ Pseudomonas Burkholderia cepacia causing CF centre epidemics in North America and Britain
22. Inapparent transmission of Pseudomonas Burkholderia cepacia among patients with cystic fibrosis